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Photodynamic therapy �P�T�� is �ased on the a�ility 
of specific su�stances�� the so-called photosensitizers 
�PS�� to accumulate selectively in tumor tissue �eing in-
jected i. v. and to �e photoactivated with light of specific 
wavelength to generate singlet oxygen and free radicals�� 
which cause destruction of tumor cells [1�� �].
The main disadvantage of the most photosensiti-
zers recently used for P�T in clinics is prolonged skin 
photosensitivity. �uring ���� months following treat-
ment with Photoheme or Photosense �Russia�� and dur-
ing 1 week following treatment with Photolon �Belarus���� 
patients should not �e exposed to direct sunlight etc. 
to prevent phototoxic reactions such as hyperemia�� 
edema and �urn of open sites of a �ody.
Creation of new PSs and appropriate lasers is not 
the only way to enhance the efficacy of P�T. New 
methods of local application of PS are �eing develo-
ped ena�ling to reduce the side effects of treatment 
and to lower its cost. So�� it has �een shown that lo-
cal application of the mono-L aspartyl chlorin e�� or 
5-aminolevulinic acid�� a precursor of endogenic PS 
protoporphyrin IX�� promotes considera�ly higher ac-
cumulation of PS in tumor tissue�� in comparison with 
normal tissues [��� 4]. The P�T using local application 
of ��% cream of 5-aminolevulimic acid for superficial 
malignant skin tumors has �een carried out [5].
The photosensitizer of the second generation — 
chlorin e�� was reported to have significant efficacy 
in killing cancer cells in vitro and in vivo. P�T with 
chlorin e�� — polyvinyl pyrrolidone complex �Photo-
lon�� administrated intravenously is a highly effective 
method for treatment of the patients with skin cancer 
and intradermal metastases of melanoma and �reast 
cancer. O�jective effect of treatment in such patients 
has �een achieved in 1��% of cases [��].
The aim of this study was to develop a technique 
and to investigate antitumor efficiency of P�T using 
Photolon in the form of � or 5% ointment. The inves-
tigation tasks were: to develop a technique of topical 
application of Photolon ointment in tumor-�earing 
rats; to study the accumulation of � and 5% Photolon 
ointment in normal and tumor tissues of la�oratory 
animals; to evaluate the efficacy of P�T with different 
concentrations of Photolon ointment applied for dif-
ferent periods — from 15 min to 5 h.
MATERIALS AND METHODS
Experimental animals and tumors. Eighty white 
randomly �red rats o�tained from the vivarium of the 
N.N. Alexandrov Research Institute of Oncology and 
Medical Radiology �Minsk�� Belarus�� were used. The 
animals received a standard diet and had permanent 
access to water. SM-1 experimental rat fi�rosarcoma 
was o�tained from the tumor strains collection of the 
N.N. Blokhin Cancer Research Centre of the Russian 
Academy of Medical Sciences �Moscow�� Russia�� and 
was passed �y serial transplantation. For experiments 
tumor homogenate was implanted su�cutaneously 
into the inguinal region �y the injection of �.5 ml of 
1�% tumor cell suspension in the Hanks’ solution. 
Before the treatment the animals were anesthetized 
with droperidol �5 mg/kg�� and fentanil ��.�5 mg/kg�� 
and restrained. All manipulations were carried out 
according to the international and scientific ethic 
standards of the quality of planning and carrying out 
of animal investigations�� specifically�� according to 
“Methodic instructions for carrying out preclinical 
investigations of pharmacokinetics of pharmacologic 
su�stances and drugs” presented in the “Guide on 
experimental �preclinical�� study of new pharmacologic 
su�stances” // Health Ministry of Russian Federation�� 
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Photosensitizer. Сhlorin e�� conjugated with polyvi-    
nyl pyrrolidone �Photolon�� produced �y Scientific Phar-
maceutical Center of RUE “Belmedpreparaty”�� Minsk�� 
Belarus�� was used as PS�� as an injection form for i. v. 
injections �control�� and as application form for external 
application �� and 5% “Photolon” ointment��.
Fluorescence diagnosis. Animals were taken for 
experiment ���7 days after the tumor inoculation�� when      
the tumors reached the size of � cm. The procedures 
were carried out in a room with light at the low level. 
Before the investigation the hair and the skin on the top 
of the tumor �1 cm��� were removed. Then �.� ml of � or 
5% Photolon ointment was applied on the surface of the 
tumor and covered with a polyethylene film and a foil to 
protect from light and drying. After the Photolon ointment 
application for 15 min�5 h�� the tumor surface was rinsed 
carefully with warm soap water solution and “Septocide-
Sinergy” antiseptic. For comparison an injection form of 
Photolon was administered into the tail vein at the dose 
of �.5 mg/kg of �ody weight of the animal.
The accumulation dynamics of PS in tumor and 
normal tissues �the skin of the contralateral thigh�� was 
recorded �y the method of the lifetime computerized flu-
orescence spectrophotometry using laser-fi�rous spec-
troanalyzer “LESA-��” with helium-neon “LHN ����-�5” 
laser �BioSpec�� Moscow�� Russia��. For monitoring in real 
time�� every time interval after injection or topical appli-
cation of the preparation�� the distal �diagnostic�� end of 
the catheter was placed over the tumor or the skin of the 
contralateral thigh to o�tain the comparative spectrum of 
the diffuse reflection and the fluorescence of the prepa-
ration. The method provides PS level monitoring under 
selected conditions of the pharmacokinetic experiment�� 
specifically�� guarantees the required follow-up duration�� 
and corresponds to general standards of selectivity�� 
precision and reproduction.
Photodynamic therapy. Photoirradiation of tumors 
was carried out ��4 h after i. v. Photolon injection at 
the dose of �/5 mg/kg. It was the time of maximum 
accumulation of the preparation according to the data 
of spectral-fluorescence investigation.
The SM-1-�earing animals treated with � or 5% of 
Photolon ointment were distri�uted into 1�� groups�� 
5 rats per group in dependence on the time of oint-
ment application. Photoirradiation was carried out in 
15�� ���� 45 min�� 1�� ��� ��� 4 and 5 h after application of 
� or 5% Photolon ointment on the SM-1 surface using 
semiconductor diode laser “L� ����-����” ���7� nm�� 
BioSpec�� Moscow�� at the dose of 1�� J/cm�. Power 
density was �.51 W/cm��� the output — �.4 W�� the light 
spot diameter — 1 cm�� irradiation time — �.�7 s.
Antitumor efficacy. Antitumor efficacy of P�T 
with the injection or application form of Photolon was 
evaluated �4 h after the treatment �y quantitive estima-
tion of necrosis area of SM-1 tumor �y a vital staining 
of tumor �earing animals with �.��% Evans’ �lue solu-
tion. The animals were sacrificed �y use of chloroform; 
the tumors were removed and fixed in a 1�% formalin 
solution. After fixation�� ����5 transversal sections 
were made in the largest diameter of the tumor. The 
sections were registered with a photocamera con-
nected with a computer. To calculate the necrosis area�� 
the method and the program of color tints computer 
scanning of histotopographic tumor sections have 
�een developed in which the algorithm of recognition 
of the stained �via�le�� tumor areas has �een fulfilled. 
Necrotic tumor areas due to direct cytotoxic effect 
or structural-functional disorders of microcirculation 
remained unstained �Fig. 1��. The main advantage of 
a designed technique was the direct determination of 
a size of tumor necrosis that allowed estimate the ef-
ficacy of P�T. The automated approach for detection of 
necrotic zones allows increase the processing rate of 
the results�� as well as to raise calculation accuracy.
fig.1. Histotopographic tumor section �efore �a�� and after 
�b�� the processing using the method of computer scanning of 
color tints
Statistical analysis. The values o�tained were 
processed using standard statistical methods of 
Origin Stat ��.1�� Microsoft Excel ���� programs. The 
significance level has �een determined as �.�5. The 
data are presented as average values ± standard 
average error.
RESuLTS AND DIScuSSION
Fig. � presents the data on Photolon accumulation      
in normal and tumor tissues of rats depending on the 
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time after i. v. injection of PS at the dose of �.5 mg/kg. 
Photolon accumulation increased in a time-dependent 
manner and achieved its maximal value at ��4 h post 
injection; then the level of a signal decreased. The cal-
culation of a selectivity ratio �contrast���� characterizing 
the ratio of Photolon fluorescence in tumor and normal 
tissues has shown that the greatest contrast �1.����.���� 
of Photolon accumulation in the tumor tissue of rats was 
scored at ���� h post injection �Ta�le 1��.
fig. 2. Photolon accumulation dynamics in rat tissue after i. v. 
injection of PS at the dose of �.5 mg/kg
The study of the ointment form of PS has shown 
that Photolon fluorescence in tumor tissues is dozens 
times higher than that in normal tissues �fluorescence 
intensity in normal tissues was not higher than 1�� rela-
tive units���� and fluorescence intensity in tumor directly 
depended on the period of application and PS concen-
tration in Photolon ointment. Maximal fluorescence in 
tumor tissue was registered after a � h ointment ap-
plication and yielded ���� and 55�� relative units for 
� and was 5% ointment respectively �Fig. ���.
fig. 3. Photolon accumulation dynamics in SM-1 tumor of rats 
following application of � and 5% Photolon ointment
Thus�� comparative spectral-fluorescence study of 
accumulation levels of the ointment and injection form 
of Byelorussian Photolon photosensitizer in rat SM-1 
tumors has shown that selectivity of its accumulation 
in tumor tissue considera�ly increases when it is ap-
plied locally.
Antitumor efficacy of P�T using topical and i. v. 
application of Photolon was compared. The data o�-
tained have shown that photoirradiation of rat SM-1 
tumor at the dose of 1�� J/cm� � h after i. v. injection 
of Photolon at the dose of �.5 mg/kg led to necrosis 
of ���.��% of tumor tissue �Ta�le ���.
Table 2. Necrosis �re� in �istotopogr�p�ic sections of ��M�1 t��or of r�ts 
�fter i. v. injection of P�oto�on �t t�e dose of 2.5 �g/kg �nd p�otoirr�di��
tion �t t�e dose of 100 J/c�2
Ti�e interv�� N��ber of sections
T��or 
sq��re, c�2
Necrosis sq��re
c�2 %
3 � 30 3.59 ± 0.13 2.15 ± 0.09 60.60 ± 2.53
Ta�le � and 4 show the data of necrosis area in 
17� histotopographic sections of SM-1 tumors after 
application of �% ointment�� and in ��� sections of 
SM-1 tumors after application of 5% ointment for 
15 min to 5 h followed �y photoirradiation at the dose of 
1�� J/cm�. The study of antitumor effect revealed the 
direct relation �etween duration of ointment applica-
tion and the size of necrotic area in histotopographic 
tumor sections. Significant antitumor efficacy of P�T 
was achieved upon application of � or 5% Photolon 
ointment for � h �necrotic area in histotopographic sec-
tions of animal tumors were 5�.�� and 77.�% respec-
tively��. Thus�� the study has shown that the antitumor 
efficacy of P�T using topical application of Photolon 
is just as high as in the case of intravenous injection 
of the drug.
Table 3. Necrosis �re� in �istotopogr�p�ic sections of ��M�1 t��or of r�ts 
�fter 2% P�oto�on oint�ent �pp�ic�tion �nd p�otoirr�di�tion �t t�e dose of 
100 J/c�2
Ti�e interv�� N��ber of sections
T��or 
sq��re, c�2
Necrosis sq��re
c�2 %
15 �in 20 2.26 ± 0.17 0.31 ± 0.03 13.30 ± 3.13
30 �in 20 2.87 ± 0.12 0.56 ± 0.03 19.70 ± 1.09
45 �in 20 2.17 ± 0.20 0.56 ± 0.05 26.80 ± 1.51
1 � 20 3.25 ± 0.20 1.07 ± 0.09 33.85 ± 2.60
2 � 25 2.35 ± 0.19 0.96 ± 0.08 41.88 ± 1.81
3 � 25 3.34 ± 0.21 1.76 ± 0.09 53.64 ± 1.31
4 � 20 2.48 ± 0.09 0.94 ± 0.07 37.70 ± 2.32
5 � 20 2.68 ± 0.15 0.74 ± 0.05 27.60 ± 0.97
Table 4. Necrosis �re� in �istotopogr�p�ic sections of ��M�1 t��or of r�ts 
�fter 5% P�oto�on oint�ent �pp�ic�tion �nd p�otoirr�di�tion �t t�e dose of 
100 J/c�2
Ti�e inter�
v��, �
N��ber 
of sections
T��or 
sq��re, c�2
Necrosis sq��re
c�2 %
15 �in 25 1.56 ± 0.07 0.48 ± 0.04 31.92 ± 2.25
30 �in 30 2.52 ± 0.12 1.13 ± 0.30 32.16 ± 1.66
45 �in 28 3.02 ± 0.11 1.62 ± 0.12 52.14 ± 2.44
1 � 35 1.72 ± 0.05 0.97 ± 0.05 58.02 ± 1.97
2 � 28 3.03 ± 0.11 1.88 ± 0.09 62.21 ± 2.05
3 � 30 4.11 ± 0.10 3.18 ± 0.09 77.80 ± 1.17
4 � 31 2.37 ± 0.21 1.33 ± 0.08 60.02 ± 2.21
5 � 25 2.51 ± 0.14 1.60 ± 0.11 61.76 ± 2.49
SM-1 experimental rat fi�rosarcoma was used as 
a model to investigate the efficacy of topical applica-
tion of chlorin e�� photosensitizer Photolon. In our 
investigation�� it was detected that the selectivity of PS 
accumulation in tumor tissue using the ointment form 
of Photolon was significantly higher than using the 
injection of Photolon. Tumor damage after P�T with 
use of Photolon ointment was found to �e just as high 
as upon intravenous injection of Photolon.
The results o�tained indicate that the level of PS 
accumulation in tumor tissue using topical application 
of chlorin e�� photosensitizer Photolon ena�les to carry 
Table 1. P�oto�on �cc�����tion contr�st in ��M�1 t��or of r�ts �fter i. v. injection of 2.5 �g/kg
Ti�e 1 � 2 � 3 � 4 � 5 � 6 � 1 d�� 2 d�� 3 d�� 4 d��
T��or 814.9 ± 40 918.0 ± 49 1030.5 ± 44 1086.7 ± 46 980.9 ± 35 760.7 ± 46 423.6 ± 14 202.0 ± 13 128.0 ± 1 101.1 ± 0,9
Nor��� tiss�es 475.5 ± 12 502.5 ± 12 541.5 ± 11 534.5 ± 11 469.8 ± 6 381.4 ± 16 288.7 ± 13 155.4 ± 4 103.9 ± 5 86.4 ± 4.2
Contr�st 1.71 1.82 1.90 2.03 2.08 1.99 1.46 1.30 1.24 1.17
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out fluorescence diagnosis and P�T of superficially 
localized malignant tumors. We can assume that clini-
cal application of Photolon ointment for photodynamic 
treatment of tumors of topical localization will allow 
avoid systemic side effects of the therapy�� simplify 
essentially the P�T technique�� decrease significantly 
the amount of PS required for the treatment and to 
receive apprecia�le economic �enefit in comparison 
with conventional methods of treatment.
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ИсследованИе фотодИнамИческой эффектИвностИ 
местного прИмененИя комплекса �лорИн  e6 — 
полИвИнИлпИрролИдон в эксперИменте 
на крыса�-носИтеля� опу�олей
Цель: исследовать противоопухолевую эффективность фотодинамической терапии с аппликационной формой комплекса 
хлорин е�� �� поливинилпирролидон�� Методы: мазь�� содержащую 2 или 5% хлорина е���� наносили на поверхность опухоли 
Са М��� крыс на ��5 мин–5 ч�� а затем определяли накопление фотосенсибилизатора и повреждение опухоли лазерным 
излучением�� Результаты: при местном введении фотосенсибилизатора избирательность накопления хлорина е�� 
в опухолевых тканях значительно возрастала�� по сравнению с внутривенным введением�� По противоопухолевой 
эффективности фотодинамической терапии местное применение комплекса хлорин е�� �� поливинилпирролидон не уступало 
внутривенному введению препарата�� Выводы: уровень накопления фотосенсибилизатора в тканях крыс при использовании 
мазевой формы комплекса хлорин е�� �� поливинилпирролидон позволяет проводить как флуоресцентную диагностику�� так 
и фотодинамическую терапию поверхностно расположенных злокачественных опухолей��
Ключевые слова: фотодинамическая терапия�� фотосенсибилизаторы�� хлорин е���� саркома М��� крыс��
